JPS60260591A - 7‐ハロ‐7‐デオキシリンコマイシン - Google Patents

7‐ハロ‐7‐デオキシリンコマイシン

Info

Publication number
JPS60260591A
JPS60260591A JP60103616A JP10361685A JPS60260591A JP S60260591 A JPS60260591 A JP S60260591A JP 60103616 A JP60103616 A JP 60103616A JP 10361685 A JP10361685 A JP 10361685A JP S60260591 A JPS60260591 A JP S60260591A
Authority
JP
Japan
Prior art keywords
chloride
lincomycin
compound
adduct
group
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP60103616A
Other languages
English (en)
Japanese (ja)
Other versions
JPH0533711B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html
Inventor
ダグラス・アラン・リビングストン
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pharmacia and Upjohn Co
Original Assignee
Upjohn Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Upjohn Co filed Critical Upjohn Co
Publication of JPS60260591A publication Critical patent/JPS60260591A/ja
Publication of JPH0533711B2 publication Critical patent/JPH0533711B2/ja
Granted legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H1/00Processes for the preparation of sugar derivatives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D295/00Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/06Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by halogen atoms or nitro radicals
    • C07D295/067Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by halogen atoms or nitro radicals with the ring nitrogen atoms and the substituents attached to the same carbon chain, which is not interrupted by carbocyclic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/02Acyclic radicals, not substituted by cyclic structures
    • C07H15/14Acyclic radicals, not substituted by cyclic structures attached to a sulfur, selenium or tellurium atom of a saccharide radical
    • C07H15/16Lincomycin; Derivatives thereof

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Health & Medical Sciences (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Cephalosporin Compounds (AREA)
  • Enzymes And Modification Thereof (AREA)
JP60103616A 1984-05-15 1985-05-14 7‐ハロ‐7‐デオキシリンコマイシン Granted JPS60260591A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US610364 1984-05-15
US06/610,364 US4568741A (en) 1984-05-15 1984-05-15 Synthesis of 7-halo-7-deoxylincomycins

Publications (2)

Publication Number Publication Date
JPS60260591A true JPS60260591A (ja) 1985-12-23
JPH0533711B2 JPH0533711B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1993-05-20

Family

ID=24444721

Family Applications (1)

Application Number Title Priority Date Filing Date
JP60103616A Granted JPS60260591A (ja) 1984-05-15 1985-05-14 7‐ハロ‐7‐デオキシリンコマイシン

Country Status (18)

Country Link
US (1) US4568741A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
EP (1) EP0161794B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
JP (1) JPS60260591A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
KR (1) KR910002224B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
AT (1) ATE54150T1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
AU (1) AU574453B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CA (1) CA1229592A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
DE (1) DE3578425D1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
DK (1) DK166390C (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
ES (1) ES8606877A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
FI (1) FI78108C (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
GR (1) GR851150B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
HK (1) HK59293A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
HU (1) HU196820B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
IL (2) IL74971A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
MX (1) MX163480B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
PT (1) PT80463B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
ZA (1) ZA852592B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1004002B (zh) * 1984-11-29 1989-04-26 厄普约翰公司 制备7-卤-7-去氧林可霉素及其类似化合物的改进方法
TW282399B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) * 1990-05-25 1996-08-01 Takeda Pharm Industry Co Ltd
DE4039750A1 (de) * 1990-12-13 1992-06-17 Basf Ag Verfahren zur entfernung von phosgen aus abgasen
JP3202960B2 (ja) 1998-02-17 2001-08-27 大塚化学株式会社 ハロゲン化剤及び水酸基のハロゲン化方法
US6565882B2 (en) * 2000-02-24 2003-05-20 Advancis Pharmaceutical Corp Antibiotic composition with inhibitor
US6544555B2 (en) 2000-02-24 2003-04-08 Advancis Pharmaceutical Corp. Antibiotic product, use and formulation thereof
US6541014B2 (en) * 2000-10-13 2003-04-01 Advancis Pharmaceutical Corp. Antiviral product, use and formulation thereof
US20020068078A1 (en) * 2000-10-13 2002-06-06 Rudnic Edward M. Antifungal product, use and formulation thereof
US20020197314A1 (en) * 2001-02-23 2002-12-26 Rudnic Edward M. Anti-fungal composition
DE60204897T2 (de) * 2001-08-28 2006-05-11 Pharmacia Corp. Kristalline freie base von clindamycin
US7199105B2 (en) * 2002-08-15 2007-04-03 Vicuron Pharmaceuticals, Inc. Lincomycin derivatives possessing antibacterial activity
MXPA05001689A (es) * 2002-08-15 2005-05-27 Vicuron Pharm Inc Derivados de lincomicina que poseen actividad antibacteriana.
GB0222522D0 (en) 2002-09-27 2002-11-06 Controlled Therapeutics Sct Water-swellable polymers
JP4828404B2 (ja) 2003-01-24 2011-11-30 ステフェル リサーチ オーストラリア プロプライエタリー リミティッド リン酸クリンダマイシン発泡体
US7256177B2 (en) 2003-06-17 2007-08-14 Vicuron Pharmaceuticals, Inc. Lincomycin derivatives possessing antibacterial activity
US7199106B2 (en) 2003-06-17 2007-04-03 Vicuron Pharmaceuticals, Inc. Lincomycin derivatives possessing antimicrobial activity
EP1648407A4 (en) * 2003-07-21 2011-08-31 Middlebrook Pharmaceuticals Inc ANTIBIOTIC PRODUCT, CORRESPONDING USE AND FORMULATION
CA2533358C (en) * 2003-07-21 2014-03-11 Advancis Pharmaceutical Corporation Antibiotic product, use and formulation thereof
AU2004258949B2 (en) * 2003-07-21 2011-02-10 Shionogi, Inc. Antibiotic product, use and formulation thereof
WO2005016311A1 (en) 2003-08-11 2005-02-24 Advancis Pharmaceutical Corporation Robust pellet
WO2005016278A2 (en) * 2003-08-12 2005-02-24 Advancis Pharmaceuticals Corporation Antibiotic product, use and formulation thereof
JP5686494B2 (ja) * 2003-08-29 2015-03-18 シオノギ インコーポレイテッド 抗生物質製剤、その使用法及び作成方法
US8460710B2 (en) * 2003-09-15 2013-06-11 Shionogi, Inc. Antibiotic product, use and formulation thereof
EP1701705A4 (en) * 2003-12-24 2007-08-08 Advancis Pharmaceutical Corp IMPROVED ABSORPTION OF DOSAGE FORMS WITH MODIFIED RELEASE
US7361743B2 (en) * 2004-02-11 2008-04-22 Pfizer Inc Lincomycin derivatives possessing antibacterial activity
WO2006014427A1 (en) * 2004-07-02 2006-02-09 Advancis Pharmaceutical Corporation Tablet for pulsed delivery
GB0417401D0 (en) 2004-08-05 2004-09-08 Controlled Therapeutics Sct Stabilised prostaglandin composition
US8778924B2 (en) * 2006-12-04 2014-07-15 Shionogi Inc. Modified release amoxicillin products
US8357394B2 (en) 2005-12-08 2013-01-22 Shionogi Inc. Compositions and methods for improved efficacy of penicillin-type antibiotics
ES2582654T3 (es) 2006-03-31 2016-09-14 Stiefel Research Australia Pty Ltd Gel en suspensión espumable
US8299052B2 (en) * 2006-05-05 2012-10-30 Shionogi Inc. Pharmaceutical compositions and methods for improved bacterial eradication
GB0613333D0 (en) 2006-07-05 2006-08-16 Controlled Therapeutics Sct Hydrophilic polyurethane compositions
GB0613638D0 (en) 2006-07-08 2006-08-16 Controlled Therapeutics Sct Polyurethane elastomers
GB0620685D0 (en) * 2006-10-18 2006-11-29 Controlled Therapeutics Sct Bioresorbable polymers
CN101205245B (zh) * 2007-12-06 2011-04-06 河南天方药业股份有限公司 盐酸克林霉素的制备方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3496163A (en) * 1965-02-08 1970-02-17 Upjohn Co 7-halo-7-deoxylincomycins and process for preparing the same
US3435025A (en) * 1966-03-18 1969-03-25 Upjohn Co 7-deoxylincomycin and analogs and isomers thereof and process for making the same
US3475407A (en) * 1967-12-22 1969-10-28 Upjohn Co Process for preparing 7(r)- and 7(s)-halolincomycins
US3509127A (en) * 1968-04-30 1970-04-28 Upjohn Co Isologs of lincomycins and process for preparing the same
US3574186A (en) * 1969-10-08 1971-04-06 Upjohn Co Process for making 7-chloro-7-deoxylincomycin and related compounds and novel intermediates produced therein
US3714141A (en) * 1970-05-26 1973-01-30 Upjohn Co Process for making 7-halolincomycins
CA1138443A (en) * 1979-03-09 1982-12-28 Tate & Lyle Patent Holdings Limited Process for the preparation of chloro-deoxysugars
CN1004002B (zh) * 1984-11-29 1989-04-26 厄普约翰公司 制备7-卤-7-去氧林可霉素及其类似化合物的改进方法

Also Published As

Publication number Publication date
CA1229592A (en) 1987-11-24
PT80463B (pt) 1987-08-19
ATE54150T1 (de) 1990-07-15
KR850008349A (ko) 1985-12-16
IL74971A0 (en) 1985-08-30
GR851150B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1985-11-25
US4568741A (en) 1986-02-04
FI851941L (fi) 1985-11-16
EP0161794A3 (en) 1987-07-29
ZA852592B (en) 1985-11-27
HU196820B (en) 1989-01-30
IL75175A0 (en) 1985-09-29
DK196185A (da) 1985-11-16
MX163480B (es) 1992-05-19
ES8606877A1 (es) 1986-05-16
FI78108C (fi) 1989-06-12
KR910002224B1 (ko) 1991-04-08
AU574453B2 (en) 1988-07-07
DE3578425D1 (de) 1990-08-02
HUT40805A (en) 1987-02-27
DK166390B (da) 1993-05-10
ES542940A0 (es) 1986-05-16
EP0161794B1 (en) 1990-06-27
JPH0533711B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1993-05-20
DK196185D0 (da) 1985-05-01
FI78108B (fi) 1989-02-28
PT80463A (en) 1985-06-01
EP0161794A2 (en) 1985-11-21
FI851941A0 (fi) 1985-05-15
HK59293A (en) 1993-06-25
AU4095085A (en) 1985-11-21
IL74971A (en) 1991-07-18
DK166390C (da) 1993-09-27

Similar Documents

Publication Publication Date Title
JPS60260591A (ja) 7‐ハロ‐7‐デオキシリンコマイシン
US4710565A (en) Thesis of 7-halo-7-deoxylincomycins
SU865125A3 (ru) Способ получени производных имидазола или их солей
DE2444322C3 (de) 3,6,8-Substituierte s-Triazolo[4,3-b]pyridazine und Verfahren zu deren Herstellung
JP3771128B2 (ja) フェブリフジンおよびフェブリフジン化合物の新規合成方法
JP2000026418A (ja) 4―フェニル―1,2,3,6―テトラヒドロピリジンの誘導体の新規の製造方法及び用いられる中間体
US3357982A (en) 1-(5h-dibenzo [a, d] cyclohepten-5-yl)-4-alkylpiperazines
JPS6033399B2 (ja) リゾホスフアチジルコリン類縁体の新規な製造法
DE69734479T2 (de) Herstellung von Thiazolen
US4889929A (en) Preparation of 1'-ethoxycarbonyl-oxyethyl esters of penicillins
JPS5942359A (ja) スルホン類の製造法
DE2143989B2 (de) Verfahren zur Herstellung von 2-Methyl-pyridin-3-ol-Derivaten
SK154294A3 (en) Method of production of 2,4,5-tribrompyrole-3-carbonitrile
HU195485B (en) Process for producing aromatic carboxylic acid derivatives and -carboxamide derivatives
DE3008902A1 (de) 1,4-dioxaspiro eckige klammer auf 4,5 eckige klammer zu decen-derivate
JP2539261B2 (ja) イミダゾ―ル誘導体
FI61700B (fi) Nytt foerfarande foer framstaellning av 2-amino-benzylaminer
JPH0256352B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
JPH0136824B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
JPS62129240A (ja) 4′−シクロプロピルフエノン誘導体
PT99378B (pt) Processo para a preparacao de intermediarios uteis para a preparacao de acido 4,5-difluoroantranilico
JPS63255255A (ja) 光学活性α−メチロシンの製造方法
JPS6310756A (ja) 5−(1−カルボキシエチル)−2−フエニルチオフエニル酢酸の製造方法
JPH08505404A (ja) 中間体としてのキノロン二硫化物
JPS6058755B2 (ja) 1,4−ジヒドロ−4−オキソニコチン酸類

Legal Events

Date Code Title Description
R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20100520

Year of fee payment: 17

EXPY Cancellation because of completion of term